Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

QHC UPSTATE MEDICAL, P.C.

NPI: 1982932463 · MONSEY, NY 10952 · Urgent Care Clinic/Center · NPI assigned 11/23/2009

$16.63M
Total Medicaid Paid
487,064
Total Claims
378,442
Beneficiaries
98
Codes Billed
2018-01
First Month
2022-06
Last Month

Provider Details

Authorized OfficialKURTZ, SETH (PRESIDENT)
NPI Enumeration Date11/23/2009

Related Entities

Other providers sharing the same authorized official: KURTZ, SETH

ProviderCityStateTotal Paid
CROWN HEIGHTS MEDICAL, P.C. MONSEY NY $56.63M
KJ MEDICAL PRACTICE PC MONROE NY $7.76M
PARK AVENUE PEDIATRICS, P.C. SPRING VALLEY NY $729K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 55,924 $1.83M
2019 134,223 $4.20M
2020 130,204 $3.97M
2021 161,640 $6.55M
2022 5,073 $68K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 67,395 58,855 $3.98M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 33,748 33,434 $3.02M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 39,418 14,465 $2.92M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 33,588 18,533 $1.43M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10,038 9,296 $909K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 39,155 14,235 $811K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 5,606 5,593 $775K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 9,887 9,795 $609K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 8,511 7,584 $231K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 37,679 35,399 $230K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 11,479 5,217 $191K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 13,046 6,667 $180K
87070 23,770 22,069 $178K
87184 23,433 21,747 $134K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 11,676 6,120 $128K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,065 1,987 $96K
12001 1,040 1,034 $84K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 4,112 2,232 $71K
90460 Immunization administration through 18 years of age via any route, first or only component 2,817 2,779 $62K
S9083 Global fee urgent care centers 423 341 $44K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 453 452 $38K
10060 374 369 $36K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 348 347 $29K
71046 Radiologic examination, chest; 2 views 1,210 1,181 $29K
93000 1,686 1,667 $29K
10061 200 194 $25K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 220 215 $25K
29125 360 360 $21K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,427 1,414 $21K
10120 128 128 $17K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 183 183 $17K
73630 799 792 $16K
36415 Collection of venous blood by venipuncture 14,076 13,619 $15K
73110 583 578 $14K
90707 182 180 $12K
11730 191 177 $12K
73140 543 541 $11K
99342 570 570 $11K
90686 906 905 $10K
81000 3,124 3,025 $10K
94760 71,491 65,448 $10K
99215 Prolong outpt/office vis 76 76 $10K
92587 282 280 $9K
90715 242 242 $9K
73610 423 421 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 496 394 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 930 914 $7K
92585 67 67 $7K
36410 666 627 $7K
73130 308 308 $6K
12011 57 57 $6K
90674 262 262 $5K
69210 115 114 $5K
12002 44 44 $4K
29131 89 89 $4K
29515 57 57 $4K
29540 219 190 $4K
73090 179 178 $3K
73080 144 138 $3K
99050 696 670 $3K
90472 Immunization administration, each additional vaccine (list separately) 124 124 $2K
90461 115 114 $2K
90656 94 94 $2K
99201 35 35 $1K
17110 17 16 $1K
73590 78 78 $1K
81025 423 416 $1K
99383 13 13 $1K
85018 562 558 $1K
E0116 Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each 81 81 $1K
0031A 23 23 $952.86
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 12 12 $894.21
90658 495 494 $826.71
29126 12 12 $735.32
99442 19 19 $654.04
V5008 Hearing screening 35 35 $620.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 56 56 $582.50
85025 Blood count; complete (CBC), automated, and automated differential WBC count 108 107 $543.70
99441 13 13 $539.37
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 43 31 $537.94
11721 28 28 $512.90
73552 15 15 $407.80
90734 12 12 $300.00
73660 13 13 $244.79
82947 62 50 $242.78
99173 123 123 $211.07
87430 12 12 $71.49
99051 16 13 $17.85
94664 26 26 $16.23
99000 673 543 $9.46
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 14 14 $5.42
A4566 Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment 19 19 $0.00
97602 76 73 $0.00
15850 30 30 $0.00
99348 90 90 $0.00
36416 72 72 $0.00
2010F 119 109 $0.00
S0630 Removal of sutures; by a physician other than the physician who originally closed the wound 14 14 $0.00